Administering biologic treatment causes suppression of the immune system, making those patients undergoing treatment more susceptible to infection.4
That’s why, prior to starting a patient on therapy, a number of leading health organizations, including the American College of Rheumatology (ACR) and American College of Gastroenterology (ACG), recommend screening patients for5-7:
Test Name |
Test Components |
Test Code |
Pre-biologic/biosimilar Screen Panel, HCV/HBV with Reflexes and QFT 1 Tube* |
Hepatitis C Antibody with Reflex to HCV RNA, PCR w/Reflex to Genotype, LiPA® Hepatitis B Surface Antigen with Reflex Confirmation Hepatitis B Surface Antibody Immunity, Quantitative Hepatitis B Core Antibody, Total, with Reflex to IgM QuantiFERON®-TB Gold Plus (1-tube option) |
|
Pre-biologic/biosimilar Screen Panel, HCV/HBV with Reflexes and QFT 4 Tubes* |
Hepatitis C Antibody with Reflex to HCV RNA, PCR w/Reflex to Genotype, LiPA® Hepatitis B Surface Antigen with Reflex Confirmation Hepatitis B Surface Antibody Immunity, Quantitative Hepatitis B Core Antibody, Total, with Reflex to IgM QuantiFERON®-TB Gold Plus (4-tube option) |
*Panel components may be ordered separately.
Learn more about our Pre-biologic Panel.
Connect with us today, and a Quest sales representative will be in touch
References
Terms of Use | Privacy Policy | Contact Us | QuestDiagnostics.com
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2019 Quest Diagnostics Incorporated. All rights reserved. |